Onconetix, Inc. ( ONCO) - Key Metrics
ONCO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$1.28 | -$0.86 | -$0.86 |
| 2026Q1 | $0.03 | -$6.71 | -$3.38 | -$3.38 |
| 2025Q4 | $0.09 | $1.73 | -$0.94 | -$0.94 |
| 2025Q3 | $0.06 | -$1.79 | -$0.65 | -$0.65 |
| 2025Q2 | $0.05 | -$1.19 | -$0.71 | -$0.71 |
ONCO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.22 |
| 2026Q1 | 0% | -0.56 |
| 2025Q4 | 0% | 18.75 |
| 2025Q3 | 0% | -21.77 |
| 2025Q2 | 0% | -43.84 |
ONCO
Price: $0.41
52 week price:
Earnings Per Share: 749.08 USD
P/E Ratio: 0.00
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.4 million